The phospholipase enzyme market is estimated to be USD 224 Million in the year 2021 and is expected to grow at a Compound annual growth rate (CAGR) of 6.15% that would take the value of the Phospholipase enzyme market to USD 432 Million for the forecast period of 2022 to 2032.
Attribute | Details |
---|---|
Market Size Value in 2021 | USD 224 Million |
Market Forecast Value in 2032 | USD 432 Million |
Global Growth Rate (2022 to 2032) | 6.15% CAGR |
Forecast Period | 2022 to 2032 |
Due to the increase in the demand for good quality convenient food like ready to eat or ready to cook due to dynamic and healthy lifestyle, higher shelf life, natural and healthy option for preservatives is likely to drive the phospholipase market. With the beneficial properties and advancement in technology, the phospholipase enzyme is expected to cause a revolution in the medicine and pharmaceutical industry.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Market Statistics | Details |
---|---|
H1,2021 (A) | 6.1% |
H1,2022 Projected (P) | 6.2% |
H1,2022 Outlook (O) | 6.8% |
BPS Change : H1,2022 (O) - H1,2022 (P) | (+) 62 ↑ |
BPS Change : H1,2022 (O) - H1,2021 (A) | (+) 68.2 ↑ |
FMI provides a review and comparison of the market growth rates and potential future development opportunities on a half-yearly basis to the globe for global markets. Favorable options offered by this enzyme are low-fat cheese that enhances phospholipid concentrations. Moreover, the market for phospholipase enzymes is anticipated to rise as a result of the rising demand for high-quality food items.
Additionally, as per capita cheese consumption increases, producers must improve cheese quality and yield to keep up with customer demand. The demand for phospholipase enzyme is therefore anticipated to rise as cheese manufacturing rises. Additionally, it aids in lessening the environmental damage caused by cheese production. Several new updates have occurred.
It has been long observed that the use of enzymes such as phospholipase, protease, and lipase delivers a better end product as compared to traditional methods of manufacturing. Various food and beverage companies are realizing the potential use of enzymes in the development of superior quality products, which is making more processes enzyme dependent.
Thus, the surging demand for enzymes from the food and beverages industry is the primary factor accelerating the demand for phospholipase A2 enzyme during the forecast period.
Key market players such as Novozyme A/S have invested in the food & beverages enzyme market recognizing the potential of the untapped market. Enzymatic solutions have seen substantial growth in the food & beverages market, more than any other sector.
In 2018, Novozyme A/S held around 48% market share of the global enzyme market and the move to enter the food and beverages sector aggressively indicates that other key market players are following its footsteps. This factor can drive the growth of the phospholipase A2 enzyme market during the forecast period.
The market's rise during the first half of the projection period is primarily attributable to the widespread usage of phospholipase enzymes in sectors such animal feed, biofuels, nutraceuticals, and personal care. They are essential in the digestion of membranes by venoms and other poisons, which allows the infection to spread.
Additionally, this enzyme is critical for signal transduction. The global phospholipase enzyme market is anticipated to grow as a result of rising health concerns like obesity and the development of stomach-related ailments.
The high cost of phospholipase enzyme is the main factor impeding the expansion of the market for this enzyme. The price of the finished product is directly impacted by an increase in production costs brought on by an increase in raw material price fluctuations. The safety and handling difficulties with phospholipase enzyme, which is sensitive to temperature and pH, are another factor that restrains market expansion.
Phospholipase A2 (PLA2) is a major enzyme found in the venoms of most snake species. Phospholipase A2 produced by venoms has potent cytotoxic effects on cancer cells, including apoptosis, cell cycle arrest, and proliferation suppression. This enzyme is employed as a chemotherapeutic medication since cancer cells have more pronounced cytotoxic effects than normal cells. Phospholipase A2 contributes to increased oxidative stress, which leads to cell death, due to its catalytic actions.
Thus, this enzyme is being researched heavily in the medical world and various medicines for patients with tumors or cancer in the initial stages, containing the Phospholipase A2 enzyme have been manufactured. Seeing the cytotoxic effects of this enzyme on cancerous cells, the phospholipase enzyme market is expected to grow rapidly in the coming years.
One of the key drivers of the phospholipase enzyme market is the expected increase in demand for vegetable oil as the world's population grows. The phospholipase enzyme is used in the synthesis of vegetable oils. Enzymatic degumming is a popular way to make high-quality vegetable oil.
Because it hydrolyzes the phospholipids in the oil and aids in the manufacture of high-quality vegetable oil without the use of a chemical degumming procedure, the phospholipase enzyme is used to degum vegetable oil. Manufacturers may make low-fat vegetable oils using the phospholipase enzyme, which appeals to health-conscious consumers. This expands the industries in which it can be applied. As a result, the need for phospholipase enzymes is likely to increase.
Over 1.9 million adults aged 18 and above were more than the ideal weight for their respective ages, in 2016. Over 650 million people in the United States were overweight or obese. In 2016, 39% of adults aged 18 and above were considered overweight (39% of men and 40% of women). Obesity affected over 13% of the world's adult population in 2016 (11% of men and 15% of women).
Obesity is a metabolic disorder marked by the accumulation of excess body fat and is linked to heart disease, high blood pressure, type 2 diabetes, and high cholesterol. Furthermore, obesity is associated with an increase in inflammatory immune cells in white adipose tissue, which is a symptom of adipose tissue dysfunction.
Phospholipase A2 is a protein and chemical combination that has anti-inflammatory and anti-obesity characteristics when consumed. Phospholipase A2 is found to have a therapeutic effect on obesity caused by a high-fat diet (HFD).
As a result, manufacturers are creating new tools and other improvements to incorporate the phospholipase enzyme into a variety of food products and beverages, further expanding the enzyme market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Consumer concerns about health and the environment have risen in recent years. Their interest in natural products has risen as a result of greater health awareness, and producers are looking for alternatives to chemical processing to develop natural and healthy products. People are turning to natural items that are safe for their health and the environment. Chemical processing not only hurts the environment but also decreases the product's nutritional value. Thus, the use of enzymes is a good alternative for product processing.
As a result, manufacturers' willingness to use enzymes is increasing, which has a positive impact on the phospholipase enzyme market.
In addition, end-use industries place a strong emphasis on developing innovative goods that are in line with their needs. With an increase in workload and hectic lifestyle, consumers are inclining towards convenient food like ready to eat or ready to cook. There is also an increase in demand for a product with increased shelf life. Such a product can have great potential usage of phospholipase.
To attract customers, it is vital to preserving the nutritional value as well as the quality of the items. So, in a nutshell, the phospholipase enzyme can be a viable choice for preserving nutritious content while also improving the finished product's quality.
The Phospholipase Enzyme Market is expected to increase which is attributed to the rising use of the enzyme in low-fat content cheese production since customers prefer low-fat content cheese for its health benefits all over the world. According to a survey, cheese is the second most popular milk solids dairy product. Manufacturers are on the search for an element that will aid in the production of low-fat content cheese as worldwide cheese consumption rises.
The phospholipase enzyme is one of the preferred substitutes because it lowers phospholipid concentrations while also promotes the preparation of the low-fat content cheese. Moreover, the increased demand for high-quality food products is expected to boost the growth of the Phospholipase Enzyme market.
In addition, as per capita, cheese consumption rises, manufacturers must raise the quality and yield of cheese in order to meet consumer demands. Therefore, due to the increase in cheese production, the demand for phospholipase enzyme is expected to increase. It also helps to reduce the impact on the environment due to cheese production.
In the Phospholipase Enzyme Market, the top companies are Genetrix Ingredient, Koninklijke DSM N.V, Novozymes A/S, Nagase & Co. Ltd., Enzo Life Sciences Inc., DuPont, Chr. Hansen Holding A/S, Aumgene Biosciences, Thermo Fisher Scientific, and others.
Attribute | Details |
---|---|
Market Size Value in 2021 | USD 224 Million |
Market Forecast Value in 2032 | USD 432 Million |
Global Growth Rate (2022 to 2032) | 6.15% CAGR |
Forecast Period | 2022 to 2032 |
Historical Data Available for | 2017 to 2021 |
Market Analysis | MT for Volume and USD Million for Value |
Key Regions Covered | North America; Europe; Asia Pacific; Africa |
Key Countries Covered | United States, Germany, Italy, France, Canada, EU, China, Spain, ASEAN, Australia, and others. |
Key Market Segments | Product type, sources, and Region |
Key Companies Profiled | Genetrix Ingredient; Koninklijke DSM N.V; Novozymes A/S; Nagase & Co. Ltd.; Enzo Life Sciences Inc.; DuPont; Chr. Hansen Holding A/S; Aumgene Biosciences;Thermo Fisher Scientific; and others. |
Pricing | Available upon Request |
North America is expected to lead the worldwide phospholipase enzyme market in terms of region. This is owing to the increasing growth of sectors such as bakery, food and drinks, and dairy in this region. The global phospholipase enzyme market may be fueled by the rising prevalence of stomach-related diseases and tumors, as well as the growing population and need for nutritious foods and suitable diets. Europe, Latin America, Asia Pacific, Middle East, and Africa are all part of the global phospholipase enzyme market.
Because of the region's booming food and beverage industry, Asia Pacific is expected to grow at a faster CAGR for the year 2022 to 2032. The market in this region is growing because of the rising consumption of healthy food products and a good diet, as well as the rising spending capacity of the population in this region.
As the food and beverage industry increases and people become more aware of health issues, the global phospholipase enzyme market is likely to grow along in these regions. The clean-label and organic product trends are projected to drive the phospholipase enzyme market in these regions. The phospholipase enzyme market here is likely to be driven by population growth, rising industrialization, and urbanization.
Food and beverage, nutraceuticals, household care, and cosmetics firms are aiming to establish themselves in developing economies due to the large population, large labor pool, and economic feasibility. This provides additional potential for phospholipase enzyme makers to develop their marketing tactics and increase sales in the South Asian and East Asian markets.
Currently Phospholipase Enzyme market is worth more than USD 224 Billion.
Phospholipase Enzyme consumption is expected to grow at a CAGR of around 6.15% during the period 2022 to 2032.
Rising demand for convenient food, Dynamic and hectic lifestyle, Changing taste and preference, health awareness and technological advancement can be considered key trends boosting Phospholipase Enzyme sales.
Market players are opting for technological advancement, new product developments, and production capacity expansion.
The top 5 producers of Phospholipase Enzyme hold around XYZ% of the market share.
The USA, Canada, France, Spain, UK, Germany, India and China are the major countries driving demand for Phospholipase Enzyme.
The major players involved in the Phospholipase Enzyme market are Genetrix Ingredient, Koninklijke DSM N.V, Novozymes A/S, Nagase & Co. Ltd., Enzo Life Sciences Inc., DuPont, Chr. Hansen Holding A/S, Aumgene Biosciences,Thermo Fisher Scientific, and others..
1. Market Overview 2. The Massive Impact of the Crisis 3. Market Dynamics 4. Key Regulations 5. Global Phospholipase Enzyme Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032 6. Global Phospholipase Enzyme Market Pricing Analysis 7. Global Phospholipase Enzyme Market Demand (Size in USD Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032 8. Global Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 8.1. Phospholipase A1 8.2. Phospholipase A2 8.3. Phospholipase C 8.4. Phospholipase B 8.5. Phospholipase D 9. Global Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Basis of Source 9.1. Microbial 9.2. Animal 9.3. Data Mining 9.4. Botanical 10. Global Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. East Asia 10.5. South Asia 10.6. Oceania 10.7. MEA 11. North America Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032 12. Latin America Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032 13. Europe Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14. East Asia Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15. South Asia Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16. Oceania Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17. Middle East and Africa Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032 18. Key Countries Phospholipase Enzyme Market Analysis 2017 to 2021 and Forecast 2022 to 2032 19. Market Structure Analysis 20. Competition Analysis 20.1. Sunson Industry Group Co., Ltd. 20.2. EUCODIS Bioscience GmbH 20.3. Bioseutica B.V. 20.4. Sanyo Fine Co., Ltd. 20.5. Novozymes A/S 20.6. DSM N.V. 20.7. Chr. Hansen Holding A/S 20.8. DuPont de Nemours, Inc. 20.9. AB Enzymes GmbH 20.10. Merck KGaA 20.11. Other Players (On Additional Requests) 21. Value Chain Analysis 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Food and Beverage Insights
View Reports